Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pham Quang X
Apr 10 17:33 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cole Jeffrey Scott
Apr 3 17:25 ET
Cadrenal Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Cole Jeffrey Scott
Apr 3 17:24 ET
Cadrenal Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Feb 14 15:39 ET
Cadrenal Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John Raymond Murphy(5.49%)
Feb 13 17:32 ET
Cadrenal Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Quang X. Pham(48.57%),The PVBQ Living Trust(23.04%)
Feb 12 21:45 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pham Quang X
Feb 12 21:45 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lisicki Robert
Jan 19 00:00 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities
Jan 19 00:00 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MURPHY JOHN RAYMOND
Jan 19 00:00 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pham Quang X
Jan 19 00:00 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Szot Matthew K
Jan 19 00:00 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WILSON GLYNN
Jan 19 00:00 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LOSORDO DOUGLAS W
Jan 19 00:00 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MURPHY JOHN RAYMOND
Oct 6, 2023 17:32 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pham Quang X
Sep 6, 2023 15:28 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pham Quang X
Sep 5, 2023 06:05 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lisicki Robert
Jul 24, 2023 17:26 ET
Cadrenal Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Lisicki Robert
Jul 24, 2023 17:25 ET
Cadrenal Therapeutics | D: Filing D
Jul 17, 2023 18:18 ET
No Data
No Data